Patient Support Services Contact Us
Image: Coherus Investors

Snapshot

Revenue & Earnings

Revenue (FY) $356.07
EBIT (Mil) (FY) $107.87
EBIT (Mil) (MRQ) $45.13
EBIT (Mil) (TTM) $107.87
EBITDA (Mil) (FY) $111.17
EBITDA (Mil) (MRQ) $46.19
EBITDA (Mil) (TTM) $111.13
Net Income Excluding Extraordinary Items (Mil) (FY) $89.83
Net Income Including Extraordinary Items (Mil) (FY) $89.83
Diluted EPS Excluding Extraordinary Items (FY) $1.23
Diluted EPS Including Extraordinary Items (FY) $1.23

Dividends

Yield (%) --
Dividend Record Date
Dividend Rate --%

Ratios

Price to Revenue (TTM) $3.23
Price to Revenue (MRQ) $2.31
Price to Revenue (FY) $3.23
Price To Cash Flow (TTM) $12.34
Price to Cash Flow (MRQ) $7.11
Price to Cash Flow (FY) $12.33
Price to Book (MRQ) $10.87
Price to Book (FY) $10.87
Total Debt to Equity (MRQ) (%) 169.55%
Total Debt to Equity (FY) (%) 169.55%
Current Ratio (MRQ) $2.98
Current Ratio (FY) $2.98

Growth

5-Year Annual Dividend Growth Rate (%) --%
5-Year Annual Revenue Growth Rate (%) 62.83%

FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months.

Copyright Thomson Reuters Corporation